SG Americas Securities, LLC

Broker-Dealer

Position in FTRE — Fortrea Holdings Inc.

CIK 1313360 NEW YORK, NY

Position in FTRE

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$2,049,716

-$593,467 QoQ

Shares Held

217,592

+42.0% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SG Americas Securities, LLC holds $695,767,973 across 174 Biotechnology names. FTRE ranks #34 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	158,278	$122,291,913
2	PTCT	Ptc Therapeutics, Inc.	879,701	$59,934,029
3	HRMY	Harmony Biosciences Holdings, Inc.	2,018,174	$56,529,053
4	JAZZ	Jazz Pharmaceuticals plc	199,705	$37,754,230
5	URGN	UroGen Pharma Ltd.	1,657,846	$29,808,071
6	ASND	Ascendis Pharma A/S	120,790	$27,628,296
7	INCY	Incyte Corp	285,152	$26,838,506
8	VRTX	Vertex Pharmaceuticals Inc / Ma	56,982	$25,444,742

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,049,716	217,592	+42.0%	Shares	Sole	2026-04-16
2025-12-31	$2,643,183	153,228	+245.9%	Shares	Sole	2026-01-09
2025-09-30	$373,031	44,303	-1.3%	Shares	Sole	2025-10-23
2025-06-30	$221,835	44,906	-65.3%	Shares	Sole	2025-08-08
2025-03-31	$976,350	129,318	+960.3%	Shares	Sole	2025-04-15
2024-12-31	$227,455	12,196	+9.5%	Shares	Sole	2025-01-17
2024-06-30	$259,984	11,139	-8.7%	Shares	Sole	2024-07-12
2023-12-31	$425,605	12,195	-56.5%	Shares	Sole	2024-01-12
2023-09-30	$800,977	28,016	—	Shares	Sole	2023-10-13
No filing history on record for this holder in this stock.